Otolaryngological perspective on patients with throat symptoms and laryngeal irritation



The diagnosis of laryngopharyngeal reflux (LPR) is increasingly common in otolaryngology practice. Patients with nonspecific throat and voice symptoms, such as throat clearing, hoarseness, cough, sore throat, and globus, are frequently treated empirically with antireflux medication by otolaryngologists and primary care physicians. Physical findings such as laryngeal erythema, edema, and posterior laryngeal mucosal thickening are also frequently attributed to LPR. The literature has been inconsistent, with few prospective, randomized trials showing efficacy for this clinical practice. Because of the lack of specific signs and symptoms of LPR, clinicians should be aware of other potential causes for these clinical presentations. Recently published studies describe the association between allergy or asthma and many of the same symptoms attributed to reflux disease. Muscle tension dysphonia can also present with hoarseness and symptoms of throat irritation. Although LPR can cause the symptoms and signs described previously, it should not be the only diagnosis considered by the evaluating physician. Failure to consider other possible causes may result in unnecessary treatment and potential delay in diagnosis. This article discusses this topic, citing some of the pertinent literature published over the past 2 years.

References and Recommended Reading

  1. 1.
    Cohen SM, Garrett CG: Hoarseness: is it really laryngopharyngeal reflux? Laryngoscope 2008, 117:363–366.Google Scholar
  2. 2.
    Delahunty JE, Cherry J: Experimentally produced vocal cord granulomas. Laryngoscope 1968, 78:1941–1947.PubMedCrossRefGoogle Scholar
  3. 3.
    Koufman JA: The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991, 101(4 Part 2 Suppl 53):1–78.PubMedGoogle Scholar
  4. 4.
    Long MD, Shaheen NJ: Extra-esophageal GERD: clinical dilemma of epidemiology versus clinical practice. Curr Gastroenterol Rep 2007, 9:195–202.PubMedCrossRefGoogle Scholar
  5. 5.
    Belafsky PC, Postma GN, Koufman JA: Validity and reliability of the reflux symptom index (RSI). J Voice 2002, 16:274–277.PubMedCrossRefGoogle Scholar
  6. 6.
    Simberg S, Sala E, Tuomainen J, Ronnemaa AM: Vocal symptoms and allergy—a pilot study. J Voice 2007 July 9 (Epub ahead of print).Google Scholar
  7. 7.
    Bhalla RK, Jones AS, Roland NJ: Prevalence of pharyngeal and laryngeal complications in adult asthmatics using inhaled corticosteroids. J Laryngol Otol 2008 Jan 18 (Epub ahead of print).Google Scholar
  8. 8.
    Koufman JA, Amin MR, Panetti M: Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders. Otolaryngol Head Neck Surg 2000, 123:385–388.PubMedCrossRefGoogle Scholar
  9. 9.
    Altman KW, Atkinson C, Lazarus C: Current and emerging concepts in muscle tension dysphonia: a 30-month review. J Voice 2005, 19:261–267.PubMedCrossRefGoogle Scholar
  10. 10.
    Milstein CF, Charbel S, Hicks DM, et al.: Prevalence of laryngeal irritation signs associated with reflux in asymptomatic volunteers: impact of endoscopic technique (rigid vs. flexible laryngoscope). Laryngoscope 2005, 115:2256–2261.PubMedCrossRefGoogle Scholar
  11. 11.
    Belafsky PC, Postma GN, Koufman JA: The validity and reliability of the reflux finding score (RFS). Laryngoscope 2001, 111:1313–1317.PubMedCrossRefGoogle Scholar
  12. 12.
    Karkos PD, Benton J, Leong SC, et al.: Trends in laryngopharyngeal reflux: a British survey. Eur Arch Otorhinolaryngol 2007, 264:513–517.PubMedCrossRefGoogle Scholar
  13. 13.
    Ford CN: Evaluation and management of laryngopharyngeal reflux. JAMA 2005, 294:1534–1540.PubMedCrossRefGoogle Scholar
  14. 14.
    Ahmed TF, Khandwala F, Abelson TI, et al.: Chronic laryngitis associated with gastroesophageal reflux: prospective assessment of differences in practice patterns between gastroenterologists and ENT physicians. Am J Gastroenterol 2006, 101:470–478.PubMedCrossRefGoogle Scholar
  15. 15.
    Qadeer MA, Phillips CO, Lopez AR, et al.: Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials. Am J Gastroenterol 2006, 101:2646–2654.PubMedGoogle Scholar
  16. 16.
    Wo JM, Koopman J, Harrell SP, et al.: Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux. Am J Gastroenterol 2006, 101:1972–1978.PubMedCrossRefGoogle Scholar
  17. 17.
    Oridate N, Takeda H, Asaka M, et al.: Acid-suppression therapy offers varied laryngopharyngeal and esophageal symptom relief in laryngopharyngeal reflux patients. Dig Dis Sci 2007 Dec 13 (Epub ahead of print).Google Scholar
  18. 18.
    Vaezi MF, Richter JE, Stasney CR, et al.: Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope 2006, 116:254–260.PubMedCrossRefGoogle Scholar
  19. 19.
    Noordzij JP, Khidr A, Evans BA, et al.: Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope 2001, 111:2147–2151.PubMedCrossRefGoogle Scholar
  20. 20.
    Steward DL, Wilson KM, Kelly DH, et al.: Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized, placebo-control trial. Otolaryngol Head Neck Surg 2004, 131:342–350.PubMedCrossRefGoogle Scholar
  21. 21.
    Belafsky PC, Vaezi MF, DeVault K: Debate: treatment of chronic throat symptoms with PPIs should be preceded by pH monitoring. Am J Gastroenterol 2006, 101:6–11.PubMedCrossRefGoogle Scholar
  22. 22.
    Joniau S, Bradshaw A, Esterman A, Carney AS: Reflux and laryngitis: a systematic review. Otolaryngol Head Neck Surg 2007, 136:686–692.PubMedCrossRefGoogle Scholar
  23. 23.
    Johnston N, Knight J, Dettmar PW, et al.: Pepsin and carbonic anhydrase isoenzyme III as diagnostic markers for laryngopharyngeal reflux disease. Laryngoscope 2004, 114:2129–2134.PubMedCrossRefGoogle Scholar
  24. 24.
    Johnston N, Dettmer PW, Lively MO, et al.: Effect of pepsin on laryngeal stress protein (Sep70, Sep53, and Hsp70) response: role in laryngopharyngeal reflux disease. Ann Otol Rhinol Laryngol 2006, 115:47–58.PubMedGoogle Scholar
  25. 25.
    Johnston N, Dettmer PW, Bishwokarma B, et al.: Activity/stability of human pepsin: implications for reflux attributed laryngeal disease. Laryngoscope 2007, 117:1036–1039.PubMedCrossRefGoogle Scholar
  26. 26.
    Johnston N, Wells CW, Blumin JH, et al.: Receptor-mediated uptake of pepsin by laryngeal epithelial cells. Ann Otol Rhinol Laryngol 2007, 116:934–938.PubMedGoogle Scholar
  27. 27.
    Thibeault SL, Smith ME, Peterson K, Ylitalo-Moller R: Gene expression changes of inflammatory mediators in posterior laryngitis due to laryngopharyngeal reflux and evolution with PPI treatment: a preliminary study. Laryngoscope 2007, 117:2050–2056.PubMedCrossRefGoogle Scholar
  28. 28.
    Belafsky PC, Rees CJ, Rodriguez K, et al.: Esophagopharyngeal reflux. Otolaryngol Head Neck Surg 2008, 138:57–61.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  1. 1.Department of OtolaryngologyVanderbilt Medical CenterNashvilleUSA

Personalised recommendations